{"url_path":"/sec/abt/8-k/2026-04-27/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1800/0001104659-26-049434-index.html","accession_number":"0001104659-26-049434","cik":"0000001800","ticker":"ABT","issuer_name":"ABBOTT LABORATORIES","edgar_url":"https://www.sec.gov/Archives/edgar/data/1800/0001104659-26-049434-index.html","primary_entity_key":"0000001800","primary_entity_name":"ABBOTT LABORATORIES"},"word_count":601,"has_tables":true,"body_markdown":"**Item 9.01****Financial Statements and Exhibits.**\n\n \n\n**Exhibit No.**\n \n**Exhibit**\n\n \n \n \n\n[3.1](tm2612318d1_ex3-1.htm)\n \n[By-Laws of Abbott Laboratories, as amended and restated, effective April 24, 2026.](tm2612318d1_ex3-1.htm)\n\n \n \n \n\n[10.1](https://www.sec.gov/Archives/edgar/data/1800/000130817926000064/abt-20260311.htm#i5771cae80df844cdb3046ede3c6a75e3_1580)\n \n[Abbott Laboratories 2026 Incentive Stock Program (incorporated by reference to Exhibit A of the Abbott Laboratories Definitive Proxy Statement on Schedule 14A filed on March 13, 2026).](https://www.sec.gov/Archives/edgar/data/1800/000130817926000064/abt-20260311.htm#i5771cae80df844cdb3046ede3c6a75e3_1580)\n\n \n \n \n\n[10.2](tm2612318d1_ex10-2.htm)\n \n[Form of Restricted Stock Unit Agreement (time-based vested) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-2.htm)\n\n \n \n \n\n[10.3](tm2612318d1_ex10-3.htm)\n \n[Form of Restricted Stock Unit Agreement for foreign employees (time-based vested) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-3.htm)\n\n \n \n \n\n[10.4](tm2612318d1_ex10-4.htm)\n \n[Form of Restricted Stock Unit Agreement (cliff vested) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-4.htm)\n\n \n \n \n\n[10.5](tm2612318d1_ex10-5.htm)\n \n[Form of Restricted Stock Unit Agreement for foreign employees (cliff vested) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-5.htm)\n\n \n \n \n\n[10.6](tm2612318d1_ex10-6.htm)\n \n[Form of Performance Restricted Stock Agreement (annual performance based) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-6.htm)\n\n \n \n \n\n[10.7](tm2612318d1_ex10-7.htm)\n \n[Form of Performance Restricted Stock Unit Agreement for foreign employees (annual performance based) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-7.htm)\n\n \n \n \n\n[10.8](tm2612318d1_ex10-8.htm)\n \n[Form of Performance Restricted Stock Agreement (interim performance based) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-8.htm)\n\n \n \n \n\n[10.9](tm2612318d1_ex10-9.htm)\n \n[Form of Performance Restricted Stock Unit Agreement for foreign employees (interim performance based) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-9.htm)\n\n \n\n \n\n[10.10](tm2612318d1_ex10-10.htm)\n \n[Form of Restricted Stock Agreement (time-based vested) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-10.htm)\n\n \n \n \n\n[10.11](tm2612318d1_ex10-11.htm)\n \n[Form of Restricted Stock Agreement (cliff vested) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-11.htm)\n\n \n \n \n\n[10.12](tm2612318d1_ex10-12.htm)\n \n[Form of Non-Qualified Stock Option Agreement under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-12.htm)\n\n \n \n \n\n[10.13](tm2612318d1_ex10-13.htm)\n \n[Form of Non-Qualified Stock Option Agreement for foreign employees under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-13.htm)\n\n \n \n \n\n[10.14](tm2612318d1_ex10-14.htm)\n \n[Form of Restricted Stock Unit Agreement for executive officers (cliff vested) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-14.htm)\n\n \n \n \n\n[10.15](tm2612318d1_ex10-15.htm)\n \n[Form of Restricted Stock Unit Agreement for foreign executive officers (cliff vested) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-15.htm)\n\n \n \n \n\n[10.16](tm2612318d1_ex10-16.htm)\n \n[Form of Performance Restricted Stock Agreement for executive officers (annual performance based) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-16.htm)\n\n \n \n \n\n[10.17](tm2612318d1_ex10-17.htm)\n \n[Form of Performance Restricted Stock Agreement for executive officers (interim performance based) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-17.htm)\n\n \n \n \n\n[10.18](tm2612318d1_ex10-18.htm)\n \n[Form of Performance Restricted Stock Unit Agreement for foreign executive officers (annual performance based) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-18.htm)\n\n \n \n \n\n[10.19](tm2612318d1_ex10-19.htm)\n \n[Form of Performance Restricted Stock Unit Agreement for foreign executive officers (interim performance based) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-19.htm)\n\n \n \n \n\n[10.20](tm2612318d1_ex10-20.htm)\n \n[Form of Restricted Stock Agreement for executive officers (time-based vested) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-20.htm)\n\n \n \n \n\n[10.21](tm2612318d1_ex10-21.htm)\n \n[Form of Restricted Stock Agreement for executive officers (cliff vested) under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-21.htm)\n\n \n \n \n\n[10.22](tm2612318d1_ex10-22.htm)\n \n[Form of Non-Qualified Stock Option Agreement for executive officers under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-22.htm)\n\n \n \n \n\n[10.23](tm2612318d1_ex10-23.htm)\n \n[Form of Non-Qualified Stock Option Agreement for foreign executive officers under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-23.htm)\n\n \n \n \n\n[10.24](tm2612318d1_ex10-24.htm)\n \n[Form of Non-Employee Director Restricted Stock Unit Agreement under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-24.htm)\n\n \n \n \n\n[10.25](tm2612318d1_ex10-25.htm)\n \n[Form of Non-Employee Director Restricted Stock Unit Agreement for foreign non-employee directors under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-25.htm)\n\n \n \n \n\n[10.26](tm2612318d1_ex10-26.htm)\n \n[Form of Non-Employee Director Non-Qualified Stock Option Agreement under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-26.htm)\n\n \n \n \n\n[10.27](tm2612318d1_ex10-27.htm)\n \n[Form of Non-Employee Director Non-Qualified Stock Option Agreement for foreign non-employee directors under the Abbott Laboratories 2026 Incentive Stock Program.](tm2612318d1_ex10-27.htm)\n\n \n\n \n\n**SIGNATURE**\n\n** **\n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**ABBOTT LABORATORIES**\n\n \n \n \n\n \n \n \n\nDate: April 27, 2026\nBy:\n/s/ Philip P.\nBoudreau\n\n \n \nPhilip P. Boudreau\n\n \n \nExecutive Vice President, Finance and Chief Financial Officer"}